To date, the majority of studies involving TB-500 have been conducted in animal models and cell cultures
For people with type 2 diabetes or clinical obesity, replacing evidence-based pharmaceutical treatment with an unproven supplement carries health risks that extend beyond simply not losing weight
NAD+ therapy can be used short-term or as part of an on-going plan, depending on your goals and your providers recommendations
That's because there's been little other help: obesity doctors "It was very disturbing because I knew some people were taking it for their weight issues and while that's wonderful for them, it was taking medicine away from me and that was very disturbing and very upsetting," Williston told CBC News
Thyroid Tumors GLP-1s, such as semaglutide, include a warning for the risk of thyroid C-cell tumors in the US
GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis